HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oleg V Kirichenko Selected Research

1- (biphenyl- 4- ylmethyl)- 1,2,3,4- tetrahydroisoquinoline- 6,7- diol

10/2008Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oleg V Kirichenko Research Topics

Disease

3Neoplasms (Cancer)
10/2008 - 02/2007
2Glioma (Gliomas)
10/2008 - 09/2006
2Carcinogenesis
08/2008 - 02/2007
1Brain Neoplasms (Brain Tumor)
10/2008
1Pneumonia (Pneumonitis)
08/2008
1Inflammation (Inflammations)
02/2007

Drug/Important Bio-Agent (IBA)

21,2,3,4-tetrahydroisoquinolineIBA
10/2008 - 09/2006
2AntioxidantsIBA
08/2008 - 02/2007
2Butylated Hydroxytoluene (BHT)IBA
08/2008 - 02/2007
2EnzymesIBA
08/2008 - 02/2007
2Proteins (Proteins, Gene)FDA Link
08/2008 - 02/2007
1EDL-155IBA
10/2008
1SolutionsIBA
10/2008
11- (biphenyl- 4- ylmethyl)- 1,2,3,4- tetrahydroisoquinoline- 6,7- diolIBA
10/2008
1Food Additives (Food Additive)IBA
08/2008
1Alcohol OxidoreductasesIBA
08/2008
1quinone (benzoquinone)IBA
02/2007
1CarcinogensIBA
02/2007
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2007
1MethylcholanthreneIBA
02/2007
1diphenyl (biphenyl)IBA
09/2006

Therapy/Procedure

2Injections
08/2008 - 02/2007
1Intraperitoneal Injections
10/2008